FGFR3 and urinary bladder carcinoma: Furthermore, R3mab was able to bind not only wtFGFR3 but also the most common FGFR3 mutants and inhibited proliferation as well as FGFR3 signaling in bladder cancer cells, exhibiting wild type and mutated variants of FGFR3.